Literature DB >> 24681722

Cancer genomes: discerning drivers from passengers.

Vivien Marx1.   

Abstract

Entities:  

Year:  2014        PMID: 24681722     DOI: 10.1038/nmeth.2891

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   28.547


× No keyword cloud information.
  9 in total

1.  Accumulation of driver and passenger mutations during tumor progression.

Authors:  Ivana Bozic; Tibor Antal; Hisashi Ohtsuki; Hannah Carter; Dewey Kim; Sining Chen; Rachel Karchin; Kenneth W Kinzler; Bert Vogelstein; Martin A Nowak
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

2.  Comment on "The consensus coding sequences of human breast and colorectal cancers".

Authors:  Gad Getz; Holger Höfling; Jill P Mesirov; Todd R Golub; Matthew Meyerson; Robert Tibshirani; Eric S Lander
Journal:  Science       Date:  2007-09-14       Impact factor: 47.728

3.  Computational approaches to identify functional genetic variants in cancer genomes.

Authors:  Abel Gonzalez-Perez; Ville Mustonen; Boris Reva; Graham R S Ritchie; Pau Creixell; Rachel Karchin; Miguel Vazquez; J Lynn Fink; Karin S Kassahn; John V Pearson; Gary D Bader; Paul C Boutros; Lakshmi Muthuswamy; B F Francis Ouellette; Jüri Reimand; Rune Linding; Tatsuhiro Shibata; Alfonso Valencia; Adam Butler; Serge Dronov; Paul Flicek; Nick B Shannon; Hannah Carter; Li Ding; Chris Sander; Josh M Stuart; Lincoln D Stein; Nuria Lopez-Bigas
Journal:  Nat Methods       Date:  2013-08       Impact factor: 28.547

Review 4.  Cancer genome landscapes.

Authors:  Bert Vogelstein; Nickolas Papadopoulos; Victor E Velculescu; Shibin Zhou; Luis A Diaz; Kenneth W Kinzler
Journal:  Science       Date:  2013-03-29       Impact factor: 47.728

5.  Highly recurrent TERT promoter mutations in human melanoma.

Authors:  Franklin W Huang; Eran Hodis; Mary Jue Xu; Gregory V Kryukov; Lynda Chin; Levi A Garraway
Journal:  Science       Date:  2013-01-24       Impact factor: 47.728

6.  Genome sequencing identifies a basis for everolimus sensitivity.

Authors:  Gopa Iyer; Aphrothiti J Hanrahan; Matthew I Milowsky; Hikmat Al-Ahmadie; Sasinya N Scott; Manickam Janakiraman; Mono Pirun; Chris Sander; Nicholas D Socci; Irina Ostrovnaya; Agnes Viale; Adriana Heguy; Luke Peng; Timothy A Chan; Bernard Bochner; Dean F Bajorin; Michael F Berger; Barry S Taylor; David B Solit
Journal:  Science       Date:  2012-08-23       Impact factor: 47.728

7.  Discovery and saturation analysis of cancer genes across 21 tumour types.

Authors:  Michael S Lawrence; Petar Stojanov; Craig H Mermel; James T Robinson; Levi A Garraway; Todd R Golub; Matthew Meyerson; Stacey B Gabriel; Eric S Lander; Gad Getz
Journal:  Nature       Date:  2014-01-05       Impact factor: 49.962

8.  Comprehensive identification of mutational cancer driver genes across 12 tumor types.

Authors:  David Tamborero; Abel Gonzalez-Perez; Christian Perez-Llamas; Jordi Deu-Pons; Cyriac Kandoth; Jüri Reimand; Michael S Lawrence; Gad Getz; Gary D Bader; Li Ding; Nuria Lopez-Bigas
Journal:  Sci Rep       Date:  2013-10-02       Impact factor: 4.379

9.  IntOGen-mutations identifies cancer drivers across tumor types.

Authors:  Abel Gonzalez-Perez; Christian Perez-Llamas; Jordi Deu-Pons; David Tamborero; Michael P Schroeder; Alba Jene-Sanz; Alberto Santos; Nuria Lopez-Bigas
Journal:  Nat Methods       Date:  2013-09-15       Impact factor: 28.547

  9 in total
  13 in total

Review 1.  Genomics in acute lymphoblastic leukaemia: insights and treatment implications.

Authors:  Kathryn G Roberts; Charles G Mullighan
Journal:  Nat Rev Clin Oncol       Date:  2015-03-17       Impact factor: 66.675

2.  Truncation- and motif-based pan-cancer analysis reveals tumor-suppressing kinases.

Authors:  Andrew M Hudson; Natalie L Stephenson; Cynthia Li; Eleanor Trotter; Adam J Fletcher; Gitta Katona; Patrycja Bieniasz-Krzywiec; Matthew Howell; Chris Wirth; Simon Furney; Crispin J Miller; John Brognard
Journal:  Sci Signal       Date:  2018-04-17       Impact factor: 8.192

3.  Quantifying gene selection in cancer through protein functional alteration bias.

Authors:  Nadav Brandes; Nathan Linial; Michal Linial
Journal:  Nucleic Acids Res       Date:  2019-07-26       Impact factor: 16.971

4.  p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry.

Authors:  Oluwole Fadare; Vinita Parkash
Journal:  Diagn Pathol       Date:  2017-11-14       Impact factor: 2.644

5.  A data mining approach for identifying pathway-gene biomarkers for predicting clinical outcome: A case study of erlotinib and sorafenib.

Authors:  David G Covell
Journal:  PLoS One       Date:  2017-08-08       Impact factor: 3.240

6.  Pan-Cancer Mutational and Transcriptional Analysis of the Integrator Complex.

Authors:  Antonio Federico; Monica Rienzo; Ciro Abbondanza; Valerio Costa; Alfredo Ciccodicola; Amelia Casamassimi
Journal:  Int J Mol Sci       Date:  2017-04-29       Impact factor: 5.923

7.  Non-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate.

Authors:  Malene Juul; Johanna Bertl; Qianyun Guo; Morten Muhlig Nielsen; Michał Świtnicki; Henrik Hornshøj; Tobias Madsen; Asger Hobolth; Jakob Skou Pedersen
Journal:  Elife       Date:  2017-03-31       Impact factor: 8.140

8.  Systematic characterization of pan-cancer mutation clusters.

Authors:  Marija Buljan; Peter Blattmann; Ruedi Aebersold; Michael Boutros
Journal:  Mol Syst Biol       Date:  2018-03-23       Impact factor: 11.429

Review 9.  Practical aspects of NGS-based pathways analysis for personalized cancer science and medicine.

Authors:  Ekaterina A Kotelnikova; Mikhail Pyatnitskiy; Anna Paleeva; Olga Kremenetskaya; Dmitriy Vinogradov
Journal:  Oncotarget       Date:  2016-08-09

10.  CScape-somatic: distinguishing driver and passenger point mutations in the cancer genome.

Authors:  Mark F Rogers; Tom R Gaunt; Colin Campbell
Journal:  Bioinformatics       Date:  2020-06-01       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.